Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e)

PHASE3CompletedINTERVENTIONAL
Enrollment

584

Participants

Timeline

Start Date

January 9, 2012

Primary Completion Date

July 31, 2016

Study Completion Date

August 31, 2016

Conditions
Community Acquired Respiratory Disease Syndrome
Interventions
DRUG

Inactive Substance

Inactive Substance will be given in a double-blind fashion for 20 full days. The treatment course includes a bolus dose on the day of randomization, 7 days of full dose (40 mg/day), 7 days of half dose (20 mg/day), and 6 days of tapering doses (12 mg/day and 4 mg/day).

DRUG

Methylprednisolone

Methylprednisolone will be given in a double-blind fashion for 20 full days. The treatment course includes a bolus dose on the day of randomization, 7 days of full dose (40 mg/day), 7 days of half dose (20 mg/day), and 6 days of tapering doses (12 mg/day and 4 mg/day).

Trial Locations (30)

13210

Syracuse VA Medical Center, Syracuse, NY, Syracuse

14215

VA Western New York Healthcare System, Buffalo, NY, Buffalo

15240

VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh

24153

Salem VA Medical Center, Salem, VA, Salem

28805

Asheville VA Medical Center, Asheville, NC, Asheville

29209

Wm. Jennings Bryan Dorn VA Medical Center, Columbia SC, Columbia

30033

Atlanta VA Medical and Rehab Center, Decatur, Decatur

32608

North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville

33125

Miami VA Healthcare System, Miami, FL, Miami

33744

Bay Pines VA Healthcare System, Pay Pines, FL, Bay Pines

38104

Memphis VA Medical Center, Memphis, TN, Memphis

40206

Robley Rex VA Medical Center, Louisville, KY, Louisville

44106

Louis Stokes VA Medical Center, Cleveland, OH, Cleveland

45220

Cincinnati VA Medical Center, Cincinnati, OH, Cincinnati

55417

Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis

73104

Oklahoma City VA Medical Center, Oklahoma City, OK, Oklahoma City

77030

Michael E. DeBakey VA Medical Center, Houston, TX, Houston

78229

South Texas Health Care System, San Antonio, TX, San Antonio

84148

VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City

85012

Phoenix VA Health Care System Carl T. Hayden VA Medical Center, Phoenix, AZ, Phoenix

89502

VA Sierra Nevada Health Care System, Reno, NV, Reno

90073

VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles

90822

VA Long Beach Healthcare System, Long Beach, CA, Long Beach

92161

VA San Diego Healthcare System, San Diego, CA, San Diego

92357

VA Loma Linda Healthcare System, Loma Linda, CA, Loma Linda

94304-1290

VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto

46202-2884

Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis

68105-1873

Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha

53295-1000

Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee

00921

VA Caribbean Healthcare System, San Juan, PR, San Juan

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT01283009 - Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e) | Biotech Hunter | Biotech Hunter